DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Neogen Chemicals Limited — Agreements,Contracts,Arrangements,MOU-XBRL

NSE 1 hr ago·31 Aug 2026, 5:43 pm

Neogen Chemicals

Neogen Chemicals Limited has informed the stock exchanges about entering into a Memorandum of Understanding (MoU) with a strategic partner. The company has not disclosed the specific details of the agreement or the identity of the partner at this time. This development signals Neogen's intent to explore new avenues for business growth and collaboration.

For investors, this news is a positive indicator of the company's proactive approach to expanding its market presence. While the MoU does not guarantee a finalized deal or immediate financial impact, it suggests that management is actively seeking opportunities to enhance the company's long-term prospects and operational capabilities.

Investors should monitor the exchange filings for further updates. Any subsequent announcements regarding the scope of the partnership or its financial implications will be crucial for understanding the potential benefits to the company's future performance.